Variant report
Variant | nsv965127 |
---|---|
Chromosome Location | chr3:162071020-162073051 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:162065911..162068435-chr3:162071341..162073387,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531944951 | chr3:162071043-162071044 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541850707 | chr3:162071124-162071125 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556460211 | chr3:162071150-162071151 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562125369 | chr3:162071205-162071206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs190136909 | chr3:162071211-162071212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75320496 | chr3:162071212-162071213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563109679 | chr3:162071242-162071243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs80313787 | chr3:162071244-162071245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs60913775 | chr3:162071330-162071331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs113358822 | chr3:162071410-162071411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs559385858 | chr3:162071411-162071412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs73035798 | chr3:162071504-162071505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547827160 | chr3:162071520-162071521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs80182584 | chr3:162071555-162071556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182729133 | chr3:162071588-162071589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs6763928 | chr3:162071591-162071592 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs546456351 | chr3:162071643-162071644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570587040 | chr3:162071659-162071660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560290775 | chr3:162071669-162071670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs564965675 | chr3:162071686-162071687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539640070 | chr3:162071691-162071692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs139553570 | chr3:162071716-162071717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs73035800 | chr3:162071745-162071746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs149719538 | chr3:162071759-162071760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs9811154 | chr3:162071771-162071772 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs575254223 | chr3:162071819-162071820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs544233535 | chr3:162071833-162071834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs564219965 | chr3:162071835-162071836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs374748933 | chr3:162071900-162071901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs397756680 | chr3:162071907-162071908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs116562600 | chr3:162071924-162071925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545671755 | chr3:162071925-162071926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs559501864 | chr3:162071969-162071970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546360091 | chr3:162071971-162071972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs375259239 | chr3:162072022-162072023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186032768 | chr3:162072026-162072027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs560735931 | chr3:162072113-162072114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542123282 | chr3:162072124-162072125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs6148167 | chr3:162072132-162072133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs33993585 | chr3:162072133-162072134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs139677101 | chr3:162072142-162072143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs5853972 | chr3:162072150-162072151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs370961692 | chr3:162072151-162072152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs374089388 | chr3:162072152-162072153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs376132909 | chr3:162072153-162072154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs370509937 | chr3:162072157-162072158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs531564427 | chr3:162072225-162072226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369387269 | chr3:162072273-162072274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs2405741 | chr3:162072275-162072276 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs114278931 | chr3:162072285-162072286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 21909424 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:162067000-162071200 | Weak transcription | Colon Smooth Muscle | Colon |
2 | chr3:162070800-162072000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr3:162070800-162072000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr3:162070800-162072000 | Enhancers | Fetal Stomach | stomach |
5 | chr3:162071000-162072000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr3:162071000-162072400 | Enhancers | Primary hematopoietic stem cells | blood |
7 | chr3:162071200-162071800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr3:162071200-162071800 | Enhancers | Colon Smooth Muscle | Colon |
9 | chr3:162071200-162071800 | Enhancers | HSMM | muscle |
10 | chr3:162071200-162072000 | Enhancers | Dnd41 | blood |
11 | chr3:162071200-162072200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
12 | chr3:162071400-162071800 | Enhancers | Fetal Kidney | kidney |
13 | chr3:162071800-162072600 | Enhancers | Muscle Satellite Cultured Cells | -- |